# Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation

> **NCT05907525** · NA · COMPLETED · sponsor: **Pusan National University Yangsan Hospital** · enrollment: 66 (actual)

## Conditions studied

- One-Lung Ventilation
- Thoracic Surgery, Video-Assisted
- Remimazolam

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** 1% propofol

## Key facts

- **NCT ID:** NCT05907525
- **Lead sponsor:** Pusan National University Yangsan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-29
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05907525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05907525, "Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05907525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*